Literature DB >> 9045054

Germ-line mutations of the p53 tumor-suppressor gene in children and young adults with second malignant neoplasms.

D Malkin, S H Friend, F P Li, L C Strong.   

Abstract

Entities:  

Mesh:

Year:  1997        PMID: 9045054     DOI: 10.1056/nejm199703063361018

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  6 in total

1.  Age-dependent changes in health status in the Childhood Cancer Survivor cohort.

Authors:  Melissa M Hudson; Kevin C Oeffinger; Kendra Jones; Tara M Brinkman; Kevin R Krull; Daniel A Mulrooney; Ann Mertens; Sharon M Castellino; Jacqueline Casillas; James G Gurney; Paul C Nathan; Wendy Leisenring; Leslie L Robison; Kirsten K Ness
Journal:  J Clin Oncol       Date:  2014-12-29       Impact factor: 44.544

Review 2.  [Update on Li-Fraumeni syndrome].

Authors:  C M Dutzmann; J Vogel; C P Kratz; K W Pajtler; S M Pfister; B B Dörgeloh
Journal:  Pathologe       Date:  2019-11       Impact factor: 1.011

Review 3.  Medulloblastoma: Molecular Classification-Based Personal Therapeutics.

Authors:  Tenley C Archer; Elizabeth L Mahoney; Scott L Pomeroy
Journal:  Neurotherapeutics       Date:  2017-04       Impact factor: 7.620

4.  Subgroup-specific prognostic implications of TP53 mutation in medulloblastoma.

Authors:  Nataliya Zhukova; Vijay Ramaswamy; Marc Remke; Elke Pfaff; David J H Shih; Dianna C Martin; Pedro Castelo-Branco; Berivan Baskin; Peter N Ray; Eric Bouffet; André O von Bueren; David T W Jones; Paul A Northcott; Marcel Kool; Dominik Sturm; Trevor J Pugh; Scott L Pomeroy; Yoon-Jae Cho; Torsten Pietsch; Marco Gessi; Stefan Rutkowski; Laszlo Bognar; Almos Klekner; Byung-Kyu Cho; Seung-Ki Kim; Kyu-Chang Wang; Charles G Eberhart; Michelle Fevre-Montange; Maryam Fouladi; Pim J French; Max Kros; Wieslawa A Grajkowska; Nalin Gupta; William A Weiss; Peter Hauser; Nada Jabado; Anne Jouvet; Shin Jung; Toshihiro Kumabe; Boleslaw Lach; Jeffrey R Leonard; Joshua B Rubin; Linda M Liau; Luca Massimi; Ian F Pollack; Young Shin Ra; Erwin G Van Meir; Karel Zitterbart; Ulrich Schüller; Rebecca M Hill; Janet C Lindsey; Ed C Schwalbe; Simon Bailey; David W Ellison; Cynthia Hawkins; David Malkin; Steven C Clifford; Andrey Korshunov; Stefan Pfister; Michael D Taylor; Uri Tabori
Journal:  J Clin Oncol       Date:  2013-07-08       Impact factor: 44.544

5.  Involvement of tumor suppressors PTEN and p53 in the formation of multiple subtypes of liposarcoma.

Authors:  A M Puzio-Kuter; S V Laddha; M Castillo-Martin; Y Sun; C Cordon-Cardo; C S Chan; A J Levine
Journal:  Cell Death Differ       Date:  2015-03-27       Impact factor: 15.828

6.  Genetic variation in the TP53 pathway and bladder cancer risk. a comprehensive analysis.

Authors:  Silvia Pineda; Roger L Milne; M Luz Calle; Nathaniel Rothman; Evangelina López de Maturana; Jesús Herranz; Manolis Kogevinas; Stephen J Chanock; Adonina Tardón; Mirari Márquez; Lin T Guey; Montserrat García-Closas; Josep Lloreta; Erin Baum; Anna González-Neira; Alfredo Carrato; Arcadi Navarro; Debra T Silverman; Francisco X Real; Núria Malats
Journal:  PLoS One       Date:  2014-05-12       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.